Nurse Practitioner, Family · Houston, TX
NPI
1417340092
Since 2015
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
1515 Holcombe Blvd
Houston, TX, 77030
Phone (713) 792-6161
Groups this clinician bills Medicare through
Medicare paid, 2024
$13K
273 services
Medicare patients, 2024
203
Average age 73
Drug cost, 2024
$2.3M
468 prescriptions
Company payments, 2025
$630
From 10 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Amandine P Ndje was code 38222 (other organ systems), 85 times for 85 patients. In total Amandine P Ndje billed 273 services in 8 codes, and Medicare paid $13K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-11-15.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 38222 Other Organ Systems | Facility | 85 | 85 | $46.68 | $3,968 |
| 99213 Office E&M - Established | Facility | 62 | 49 | $44.27 | $2,745 |
| 99214 Office E&M - Established | Facility | 52 | 37 | $63.10 | $3,281 |
| 99441 Telephone Services | Facility | 36 | 32 | $23.63 | $851 |
| 99215 Office E&M - Established | Facility | 14 | 11 | $97.59 | $1,366 |
| 38220 Other Organ Systems | Facility | 12 | 12 | $37.82 | $454 |
By year: 2022 $16K for 344 services; 2023 $16K for 337 services; 2024 $13K for 273 services.
Medicare prescription drug claims, 2024
In 2024, the drug Amandine P Ndje prescribed most often to Medicare patients was Valacyclovir (Valacyclovir Hcl), with 46 prescriptions and refills. In total Amandine P Ndje wrote 468 Medicare prescriptions that cost $2.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Valacyclovir Valacyclovir Hcl | 46 | 104 | 19 | $1,713 |
| Potassium Chloride Generic | 33 | 39 | 21 | $853 |
| Cefpodoxime Proxetil Generic | 31 | 33 | Under 11 | $11K |
| Posaconazole Generic | 29 | 29 | Under 11 | $59K |
| Jakafi Ruxolitinib Phosphate | 28 | 28 | Under 11 | $472K |
| Tramadol Hcl Generic | 23 | 23 | Under 11 | $99.92 |
| Tibsovo Ivosidenib | 21 | 21 | Under 11 | $668K |
| Calquence Acalabrutinib Maleate | 21 | 21 | Under 11 | $308K |
| Bosulif Bosutinib | 19 | 19 | Under 11 | $319K |
| Voriconazole Generic | 14 | 14 | Under 11 | $2,252 |
| Cresemba Isavuconazonium Sulfate | 13 | 13 | Under 11 | $79K |
| Lactulose Generic | 11 | 11 | Under 11 | $45.89 |
Brand drugs: 153 claims; generic drugs: 315 claims; opioid claims: 23.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Amandine P Ndje $630 ($630 in general payments such as food, travel and fees) from 10 companies. The largest payer was Lilly USA, LLC with $144.
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC LLY | 2 | $144 |
| Astellas Pharma US Inc 4503.T | 3 | $90.2 |
| GlaxoSmithKline, LLC. GSK | 3 | $75.61 |
| AstraZeneca Pharmaceuticals LP AZN | 2 | $64.62 |
| Sobi, Inc SOBI.ST | 2 | $63.58 |
| PharmaEssentia USA Corporation 6446.TW | 2 | $57.08 |
| Celgene Corporation BMY | 2 | $50.86 |
| Syndax Pharmaceuticals, Inc. SNDX | 1 | $32.06 |
| Azurity Pharmaceuticals, Inc. | 2 | $30.62 |
| Adaptive Biotechnologies Corporation ADPT | 1 | $21.2 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.